These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37839143)

  • 1. Phenolic chalcones as agents against Trichomonas vaginalis.
    Oliveira LR; Trein MR; Assis LR; Rigo GV; Simões LPM; Batista VS; Macedo AJ; Trentin DS; Nascimento-Júnior NM; Tasca T; Regasini LO
    Bioorg Chem; 2023 Dec; 141():106888. PubMed ID: 37839143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Trichomonas vaginalis activity of chalcone and amino-analogues.
    Trein MR; Rodrigues E Oliveira L; Rigo GV; Garcia MAR; Petro-Silveira B; da Silva Trentin D; Macedo AJ; Regasini LO; Tasca T
    Parasitol Res; 2019 Feb; 118(2):607-615. PubMed ID: 30535524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichomonas vaginalis NTPDase inhibited by lycorine modulates the parasite-neutrophil interaction.
    Petró-Silveira B; Rigo GV; da Silva Trentin D; Macedo AJ; Sauer E; de Oliveira Alves E; Tallini LR; Garcia SC; de Souza Borges W; Zuanazzi JÂS; Tasca T
    Parasitol Res; 2020 Aug; 119(8):2587-2595. PubMed ID: 32524267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2'-Hydroxychalcones as an alternative treatment for trichomoniasis in association with metronidazole.
    das Neves RN; Sena-Lopes Â; Alves MSD; da Rocha Fonseca B; da Silva CC; Casaril AM; Savegnago L; de Pereira CMP; Ramos DF; Borsuk S
    Parasitol Res; 2020 Feb; 119(2):725-736. PubMed ID: 31853622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiparasitic activity of furanyl N-acylhydrazone derivatives against Trichomonas vaginalis: in vitro and in silico analyses.
    Alves MSD; das Neves RN; Sena-Lopes Â; Domingues M; Casaril AM; Segatto NV; Nogueira TCM; de Souza MVN; Savegnago L; Seixas FK; Collares T; Borsuk S
    Parasit Vectors; 2020 Feb; 13(1):59. PubMed ID: 32046788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in silico trichomonacidal activity of 2,8-bis(trifluoromethyl) quinoline analogs against Trichomonas vaginalis.
    Alves MSD; Sena-Lopes Â; das Neves RN; Casaril AM; Domingues M; Birmann PT; da Silva ET; de Souza MVN; Savegnago L; Borsuk S
    Parasitol Res; 2022 Sep; 121(9):2697-2711. PubMed ID: 35857093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States.
    Butler SE; Augostini P; Secor WE
    Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Products as New Treatment Options for Trichomoniasis: A Molecular Docking Investigation.
    Setzer MS; Byler KG; Ogungbe IV; Setzer WN
    Sci Pharm; 2017 Jan; 85(1):. PubMed ID: 28134827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a subversive substrate of Trichomonas vaginalis purine nucleoside phosphorylase and the crystal structure of the enzyme-substrate complex.
    Zang Y; Wang WH; Wu SW; Ealick SE; Wang CC
    J Biol Chem; 2005 Jun; 280(23):22318-25. PubMed ID: 15817485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of SQ109 on Trichomonas vaginalis.
    de Souza TG; Granado R; Benaim G; de Souza W; Benchimol M
    Exp Parasitol; 2023 Jul; 250():108549. PubMed ID: 37196704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and Persistent Questions in the Treatment of Trichomoniasis.
    de Brum Vieira P; Tasca T; Secor WE
    Curr Top Med Chem; 2017; 17(11):1249-1265. PubMed ID: 27697044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Trichomonas vaginalis activity and chemical analysis of metabolites produced by marine-associated fungi.
    Senger FR; Campos-Silva R; Landell MF; Silva DB; Menezes CB; Rigo GV; Silva LN; Trentin DS; Macedo AJ; Tasca T
    Parasitol Res; 2022 Mar; 121(3):981-989. PubMed ID: 35113221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triosephosphate isomerase as a therapeutic target against trichomoniasis.
    Benítez-Cardoza CG; Brieba LG; Arroyo R; Rojo-Domínguez A; Vique-Sánchez JL
    Mol Biochem Parasitol; 2021 Nov; 246():111413. PubMed ID: 34537286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of 120 kDa Pyruvate:Ferredoxin Oxidoreductase on Pathogenicity of Trichomonas vaginalis.
    Song HO
    Korean J Parasitol; 2016 Feb; 54(1):71-4. PubMed ID: 26951982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold(I) Phosphine Derivatives with Improved Selectivity as Topically Active Drug Leads to Overcome 5-Nitroheterocyclic Drug Resistance in
    Miyamoto Y; Aggarwal S; Celaje JJA; Ihara S; Ang J; Eremin DB; Land KM; Wrischnik LA; Zhang L; Fokin VV; Eckmann L
    J Med Chem; 2021 May; 64(10):6608-6620. PubMed ID: 33974434
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis.
    Küng E; Pietrzak J; Klaus C; Walochnik J
    Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil.
    da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T
    Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
    Moya IA; Su Z; Honek JF
    Future Med Chem; 2009 Jul; 1(4):619-43. PubMed ID: 21426030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive characterization of purine and pyrimidine transport activities in Trichomonas vaginalis and functional cloning of a trichomonad nucleoside transporter.
    Natto MJ; Miyamoto Y; Munday JC; AlSiari TA; Al-Salabi MI; Quashie NB; Eze AA; Eckmann L; De Koning HP
    Mol Microbiol; 2021 Dec; 116(6):1489-1511. PubMed ID: 34738285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug targets and mechanisms of resistance in the anaerobic protozoa.
    Upcroft P; Upcroft JA
    Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.